InvestorsHub Logo

cameron12x

12/13/14 5:45 PM

#28147 RE: dr_lowenstein #28144

This is very true. While there is cause for optimism there are no guarantees in life. Especially in biotech.

The combo trial with Keytruda has yet to be proven. That is what the P2b trial is all about. It could fail, or it could be a smashing success. No one knows at this point.

For the hope of cancer patients and investors (me, selfishly included), I'm betting on the latter outcome. Keeping fingers crossed.

Milesblue42

12/14/14 7:12 PM

#28154 RE: dr_lowenstein #28144

Dr. Low advise on Free PD-1 link status

Please advise on the active link to where Merck free PD-1 is available, thanks.

Now surely since OncoSec was given PD-1 by Merck it should be available to anyone.....right?


Kinda odd now why is OncoSec working with Merck.......hmmmm. Oh that's right the imaginary speculation that OnooSec is creating an impression....by working with Merck......wait what?